Researchers pay tribute to Arvid Carlsson, who was awarded the Nobel Prize for his research into dopamine, and evaluate what his research means to modern neuroscience.
Anti-psychotic drugs do not only block dopamine signaling in the brain, they also block dopamine signaling in the pancreas. Blocking dopamine signaling in the pancreas leads to uncontrolled production of blood-glucose regulating hormones, increasing obesity and diabetes risks.
Selective estrogen treatments appear to reduce symptoms of Parkinson's disease in male mice. The study sheds light on sex-based differences associated with the disease and may provide new therapeutic avenues for treatment.
Study provides first concrete examples of how the microbiome can interfere with a drug's intended path throughout the body.
Researchers used a new technique to discover what happens when Parkinson's patients receive cell transplants.
Grafting neurons derived from a monkey's own stem cells reversed the debilitating and mental health symptoms associated with Parkinson's disease. The treatment shows promise for alleviating the symptoms of Parkinson's in humans.
Researchers hope discovery will pave the way to developing new methods for earlier diagnosis of Parkinson's disease.
Researchers have uncovered what goes on in our brains when we are faced with the decision to take a risk or play it safe.
Drug combination targets brain circuits in the nucleus accumbens and completely eliminate chronic pain behavior.
Researchers have developed a new mathematical algorithm that can detect dyskinesia in Parkinson's patients.
Parkinson's disease involves monocytic alterations in the blood. The cells have reduced viability and are unresponsive to specific stimuli, which could have relevant consequences for the progression of Parkinson's. Immune modulation medications may be a new treatment option to inhibit neurodegeneration associated with PD.
A new study reports L-DOPA may be able to delay or prevent macular degeneration associated with aging.
